Recent editions
- March 2014
The 1st EORTC Cancer Survivorship Summit addressed the practical problems faced by cancer patients. - February 2014
Charles Swanton on a study that maps genetic changes in cancers over time. - January 2014
Presidents of various cancer societies make predictions for the coming year. - December 2013
Precision diagnostics have great potential, but changes are needed to make them more available. - November 2013
Highlights of the European Cancer Congress - cancer society presidents give their view. - October 2013
Richard Schilsky on the changes needed as personalised medicine enters the clinic. - September 2013
A new advance in immunotherapy is discussed by Jean-Charles Soria and Caroline Robert. - July/August 2013
EORTC President Roger Stupp on challenges for clinical trials research. - June 2013
A look ahead to the European Cancer Congress in Amsterdam in September. - May 2013
Vincenzo Valentini explores the themes of the 2013 ESTRO forum.
EJC News Focus – May 2013
Highlights of 2nd ESTRO Forum
By the year 2020, it is estimated that for every tumour, data will be available on 10,000 markers related to survival. How are clinicians to make sense – and practical use – of it all?
According to ESTRO President, Vincenzo Valentini, a good way to start might be to involve radiation oncologists who already have expertise in complex imaging and dose-planning models. The decision models of the future will become even more sophisticated, he says, able to codify quality of life so that the needs of individual patients can be met.
This was just one of the themes of the 2nd ESTRO Forum (Geneva; 19-23 April 2013). Others included the combination of radiation therapy and drugs; and the use of a single shot of radiotherapy to control pain. Here Vincenzo Valentini discusses the highlights of the forum with Helen Saul.